US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 11.770
  • +0.770+7.00%
Close Nov 8 16:00 ET
  • 11.800
  • +0.030+0.25%
Post 20:01 ET
637.75MMarket Cap-3010P/E (TTM)

Emergent BioSolutions Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Emergent BioSolutions Q3 2024 Estimates Date

Currency：USDNov 6, 2024

Estimate YoY
Revenue
297.50M
+9.98%
EPS
-0.31
+93.82%
Analyst Rating
Buy

Nov 7, 2024

Emergent BioSolutions Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 259.000M --
Nov 6, 2024 2024/Q3 293.800M / 297.500M --
Aug 6, 2024 2024/Q2 254.700M / 190.000M --
May 1, 2024 2024/Q1 300.400M / 220.250M --
Mar 6, 2024 2023/Q4 276.600M / 274.000M --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 259.000M--
Nov 6, 20242024/Q3293.800M / 297.500M--
Aug 6, 20242024/Q2254.700M / 190.000M--
May 1, 20242024/Q1300.400M / 220.250M--
Mar 6, 20242023/Q4276.600M / 274.000M--

Unlock Free Earnings Estimates

Emergent BioSolutions Earnings Reports

  • Emergent BioSolutions | 10-Q: Quarterly report

    Nov 8 01:34

  • Emergent BioSolutions | 10-Q: Q2 2024 Earnings Report

    Aug 8 02:33

  • Emergent BioSolutions | 10-Q: Q1 2024 Earnings Report

    May 3 01:50

  • Emergent BioSolutions | 10-K: FY2023 Annual Report

    Mar 9 05:28

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 7, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Mpox (monkeypox)
    Mpox (monkeypox)
    Intraday-0.45%